Skip to main content
  • BioFreedom Stent May Not Measure Up to Orsiro After All

    Conclusion of non-inferiority withdrawn after statistical error is corrected

    After discovering a statistical error in their initial analysis, leaders of the SORT OUT IX trial said this week that the BioFreedom stent may not be non-inferior to competitor Orsiro after all.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details